Armata Pharmaceuticals, Inc. ARMP
3.74
0.12
3.31%
as of 25 Sep
- Market cap
- $136.5M
- P/E
- 0.0×
Follow ARMP
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
P/S ratio |
46.41 | 9.98 | 24.69 | 6.85 | 29.52 | 58.03 | — | — | 56.07 | 18.55 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
P/Operating CF |
(34.10) | (8.44) | (13.80) | (3.60) | (15.36) | (7.76) | — | — | (2.72) | (3.22) |
P/B ratio |
0.00 | 0.00 | 0.00 | 1.05 | 5.20 | 2.59 | — | — | 0.83 | 0.50 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 1.16 | 6.03 | 3.18 | — | — | 0.86 | 0.51 |
EV/Sales |
123.75 | 22.68 | 42.85 | 13.02 | 35.72 | 62.18 | — | — | 11.44 | (3.42) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.04 |
EV/Operating CF |
(23.56) | (4.05) | (4.09) | (2.21) | (6.78) | (2.87) | — | — | (0.14) | 0.08 |
EV/FCF |
(23.07) | (3.85) | (3.49) | (2.07) | (6.42) | (2.75) | — | — | (0.14) | 0.08 |
Quick Ratio |
1.02 | 0.21 | 1.03 | 0.94 | 2.76 | 1.52 | 1.24 | 4.76 | 2.61 | 1.61 |
Current Ratio |
1.19 | 0.23 | 1.16 | 1.09 | 3.11 | 1.62 | 1.36 | 5.10 | 2.74 | 1.78 |
Net Debt/EBITDA |
(7.07) | (2.07) | (1.72) | (0.94) | (1.22) | (0.17) | 0.17 | 0.59 | 0.33 | 0.21 |
Debt/Assets |
334.18% | 109.20% | 83.68% | 50.94% | 54.45% | 33.28% | 11.25% | 0.00% | 0.00% | 4.42% |
Debt/Equity |
(1.18) | (1.97) | (2.57) | 1.35 | 1.50 | 0.70 | 0.20 | 0.00 | 0.00 | 0.08 |
Asset Turnover |
0.06 | 0.06 | 0.05 | 0.07 | 0.08 | 0.03 | 0.00 | 0.00 | 0.01 | 0.01 |
Operating CF/Net income |
0.15 | 1.99 | 0.69 | 0.88 | 1.02 | 0.82 | 0.80 | 0.64 | 0.72 | 0.44 |
Capex/Depreciation |
(0.35) | (1.42) | (8.37) | (2.48) | (1.12) | (0.74) | (0.10) | (0.60) | (0.16) | (0.76) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 130.37% | 47.24% | (3,439.35%) | (120.10%) | (104.65%) | (132.62%) | (174.80%) | (216.56%) | (147.11%) | (216.39%) | |
| (212.83%) | (20.47%) | (71.11%) | (44.59%) | (42.38%) | (68.28%) | (97.40%) | (130.06%) | (87.66%) | (97.80%) | |
ROIC |
(77.26%) | (71.53%) | (69.60%) | (32.97%) | (28.04%) | (60.34%) | (108.07%) | 0.00% | (388.51%) | (303.45%) |
Return on Tangible Assets |
(1,249.00%) | 79.81% | (452.78%) | (637.49%) | (186.72%) | (358.45%) | (491.52%) | (144.27%) | (303.28%) | (631.04%) |
Average Days of Receivables |
35.13 | 52.49 | 271.03 | 565.33 | 243.85 | 248.80 | — | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
483.63% | 665.37% | 745.64% | 635.75% | 447.36% | 1,755.04% | 0.00% | 0.00% | 2,505.22% | 2,183.85% |
Selling, General and Administrative Expense of Revenue |
253.04% | 254.81% | 257.21% | 135.02% | 185.09% | 967.92% | 0.00% | 0.00% | 6,600.00% | 3,235.77% |
Intangible Assets out of Total Assets |
0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.09 | 0.14 | 0.02 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
53.22% | 55.91% | 20.71% | 56.37% | 64.42% | 422.24% | 0.00% | 0.00% | 1,060.00% | 767.31% |
Graham Net Nets |
(1.25) | (1.84) | (0.99) | (0.87) | (0.22) | (0.20) | — | — | 0.31 | (0.44) |
Graham Number |
25.52 | 3.94 | 6.18 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Earnings Yield |
(76.43%) | (28.11%) | (61.61%) | (99.09%) | (17.70%) | (47.65%) | — | — | (345.69%) | (531.03%) |
Free Cash Flow Yield |
(11.56%) | (58.94%) | (49.68%) | (91.96%) | (18.83%) | (39.03%) | — | — | (143.46%) | (225.71%) |
Revenue per Share |
0.14 | 0.14 | 0.13 | 0.16 | 0.19 | 0.05 | 0.00 | 0.00 | 0.25 | 3.70 |
Operating CF per Share |
(0.71) | (1.04) | (1.31) | (0.95) | (0.98) | (1.11) | (1.99) | (2.28) | (20.16) | (150.87) |
Capex per Share |
(0.01) | (0.05) | (0.23) | (0.06) | (0.05) | (0.05) | (0.02) | (0.17) | (0.13) | (3.97) |
Free Cash Flow per Share |
(0.73) | (1.09) | (1.54) | (1.01) | (1.03) | (1.16) | (2.01) | (2.46) | (20.29) | (154.84) |
Cash per Share |
0.24 | 0.26 | 0.37 | 0.43 | 0.43 | 0.59 | 0.77 | 2.08 | 11.25 | 81.24 |
Shareholders Equity per Share |
(6.03) | (1.33) | (0.89) | 1.05 | 1.05 | 1.15 | 1.86 | 1.65 | 16.95 | 138.31 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(6.03) | (1.33) | (0.89) | 1.05 | 1.05 | 1.15 | 1.86 | 1.65 | 16.95 | 138.31 |
Free Cash Flow |
(26.30) | (39.43) | (55.56) | (34.69) | (24.88) | (19.09) | (15.71) | (11.44) | (9.25) | (10.88) |
Working Capital |
1.72 | (36.94) | 2.69 | 2.17 | 10.18 | 4.14 | 1.78 | 8.33 | 3.42 | 2.78 |
Capital Expenditures |
(0.54) | (1.88) | (8.13) | (2.21) | (1.30) | (0.82) | (0.13) | (0.81) | (0.06) | (0.28) |
Net Current Asset Value |
(284.81) | (123.15) | (111.28) | (32.71) | (29.38) | (9.81) | (4.20) | 3.51 | 1.98 | (2.12) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.04 |
Capex to Sales |
0.11 | 0.36 | 1.80 | 0.40 | 0.29 | 1.00 | 0.00 | 0.00 | 0.50 | 1.07 |
Net Profit Margin |
(3,544.03%) | (365.60%) | (1,524.51%) | (670.24%) | (517.55%) | (2,695.14%) | 0.00% | 0.00% | (11,163.48%) | (9,336.92%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.10 | 0.08 | 0.25 | 0.53 | 0.54 | 0.62 | 0.42 | 0.46 | 0.34 |
Cash ROIC |
(80.74%) | (91.25%) | (94.07%) | (36.19%) | (35.01%) | (48.77%) | (75.65%) | (79.94%) | (77.80%) | (71.92%) |
Accounts Receivable Turnover |
8.07 | 2.52 | 0.76 | 0.96 | 2.52 | 2.40 | — | — | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.61 | 2.05 | 5.95 | 5.76 | 1.78 | 0.34 | — | — | — | — |
Average Payables |
1.88 | 3.87 | 5.86 | 4.15 | 2.10 | 1.60 | 0.91 | 1.25 | 2.35 | 1.89 |
Average Assets |
81.66 | 92.40 | 97.10 | 82.80 | 54.64 | 32.48 | 20.00 | 12.84 | 14.65 | 24.82 |
Average Common Equity |
(133.31) | (40.04) | 2.01 | 30.74 | 22.13 | 16.73 | 11.14 | 7.71 | 8.73 | 11.22 |
Columns are period end dates